Target intelligence / Profile preview

GC-rich promoter binding protein 1 (GPBP1)

Target
GPBP1
Molecular classification
Transcription factor
01

Overview

GC-rich promoter binding protein 1 (GPBP1) is a protein coding gene primarily identified for its role as a GC-rich promoter-specific transactivating transcription factor. It was initially isolated from atherosclerotic vascular tissue, where it was found to be expressed predominantly in smooth muscle cells, though certain transcript variants are ubiquitous. GPBP1 binds to GC-rich sequences in DNA promoters, influencing the transcription of genes involved in vascular function and potentially the pathogenesis of atherosclerosis. Although it is associated with processes such as vascular remodeling and has altered expression in some tumors and cardiovascular diseases, there is currently no evidence indicating it is used as a therapeutic target, nor are there drugs specifically known to act on it. Multiple alternatively spliced isoforms exist, and orthologs are present in model organisms including mouse and rat. Alternative names include vasculin and SSH6.

Other names
VasculinVascular wall-linked proteinSSH6DKFZp761C169GPBP
02

Mechanism of action

Not directly applicable; no known mechanism of action for drugs specifically targeting GPBP1 as it is not a conventional drug target

03

Biological functions

DNA bindingTranscription activation (specifically at GC-rich promoters)Regulation of gene expressionMay be involved in vascular development and atherosclerosis
04

Disease associations

AtherosclerosisCancer (via expression changes in tumors)Cardiovascular disease (vascular remodeling, plaque development)
05

Safety considerations

Not applicable, as GPBP1 is not currently a drug target
06

Interacting drugs

None directly characterized as interacting with GPBP1 as a therapeutic target; some datasets report drugs associated with changes in GPBP1 gene expression but not direct binding or inhibition
07

Biomarkers

No established biomarkers for patient selection or efficacy monitoring; possible relevance in vascular disease or some cancers (expression level changes)

Beyond the preview

Go deeper on GC-rich promoter binding protein 1 (GPBP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GC-rich promoter binding protein 1 (GPBP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call